Larger CTCs (orange) are trapped intact and alive in vortices separating them from small red blood cells (red) and white blood cells (purple) using the Vortex microfluidic chip.
Vortex technology harnesses inertial microfluidics to isolate clinically relevant CTCs without filters, antibodies, or reagents—just a simple disposable cartridge. By preserving CTCs in their native, viable state, it ensures high-quality samples for accurate downstream analysis.
Vortex’s technology enables comprehensive multi-omics analysis of CTCs for deeper insights into cancer biology.
